Viromed Medical AG (VMED.DE) Forecast, Price Target & Analyst Ratings

FRA:VMED • DE000A3MQR65

Current stock price

4.08 EUR
-0.12 (-2.86%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Viromed Medical AG (VMED.DE).

Forecast Snapshot

Consensus Price Target

Price Target
€10.20
+ 150.00% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
N/A
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
€10.20
Upside
+ 150.00%
From current price of €4.08 to mean target of €10.20, Based on 7 analyst forecasts
Low
€10.10
Median
€10.20
High
€10.50

Price Target Revisions

1 Month
N/A
3 Months
N/A

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for VMED.DE. The average price target is 10.2 EUR. This implies a price increase of 150% is expected in the next year compared to the current price of 4.08.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

VMED Current Analyst RatingVMED Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

VMED Historical Analyst RatingsVMED Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
VMED.DE was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about VMED.DE.
In the previous month the buy percentage consensus was at a similar level.
VMED.DE was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026
Revenue
YoY % growth
VMED.DE revenue by date.VMED.DE revenue by date.
N/AN/A
480.41%
EBITDA
YoY % growth
VMED.DE ebitda by date.VMED.DE ebitda by date.
N/AN/A
700.00%		N/A
-12.50%		N/A
1,185.71%
EBIT
YoY % growth
VMED.DE ebit by date.VMED.DE ebit by date.
-360K-440K
-22.22%		N/A
262.27%		N/A
1,171.43%
Operating Margin
VMED.DE operating margin by date.VMED.DE operating margin by date.
N/AN/AN/AN/A
EPS
YoY % growth
VMED.DE eps by date.VMED.DE eps by date.
N/AN/A
100.00%		N/AN/A
2,600.00%

All data in EUR

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

VMED.DE Yearly Revenue VS EstimatesVMED.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 10M 20M 30M 40M 50M
VMED.DE Yearly EPS VS EstimatesVMED.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2025 2026 0 0.1 0.2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

Viromed Medical AG / VMED.DE Forecast FAQ

What do analysts expect the price target to be for Viromed Medical AG (VMED.DE)?

7 analysts have analysed VMED.DE and the average price target is 10.2 EUR. This implies a price increase of 150% is expected in the next year compared to the current price of 4.08.

What is the consensus rating for Viromed Medical AG (VMED.DE) stock?

The consensus rating for Viromed Medical AG (VMED.DE) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.